Non-invasive methods of the quantification of fibrosis may help to assess the development of fibrosis at a specific moment of the evolution of the disease, in the order to decide the initiation of treatment with ursodeoxycholic acid which may slow the progression to hepatic cirrhosis: * FibroTest, * The ultrasound impulse elastography, Fibroscan (FS) * Ultrasound Elastography by ShearWave (SWE) * Magnetic resonance elastography (MRE). The purpose of this study is to assess the contribution of these methods in the diagnosis of hepatic fibrosis during the evolution of the cystic fibrosis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measure of hepatic elasticity by Fibro Test
Timeframe: Day 0
Measure of hepatic elasticity by the ultrasound impulse elastography, Fibroscan (FS)
Timeframe: Month 12